Concepedia

Jonathan Oliva

JO

5

Publications

249

Citations

5

H-Index

2013

Active since

Affiliations

Saint Louis University(Current)

University of Rochester Medical Center

Guangzhou Institutes of Biomedicine and Health

University of Washington

Chinese Academy of Sciences

Jonathan Oliva is an author at Saint Louis University specializing in drug discovery, drug resistance, and antimicrobial resistance.

ORCID

Top concepts

Publications per year

2013–2019

5

Publications

5

Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy

Jonathan Oliva, Scott Galasinski, Amelia Richey et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 87 citations · Full text

BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells

Amy E. Campbell, Jonathan Oliva, Matthew Yates et al. · Skeletal Muscle · 2017 · 63 citations · Full text

Evaluation of Aminohydantoins as a Novel Class of Antimalarial Agents

Marvin J. Meyers, Micky D. Tortorella, Jing Xu et al. · ACS Medicinal Chemistry Letters · 2013 · 39 citations · Full text

Inhibitors of Arg-Gly-Asp-Binding Integrins Reduce Development of Pancreatic Fibrosis in Mice

Barbara Ulmasov, Brent A. Neuschwander‐Tetri, Jinping Lai et al. · Cellular and Molecular Gastroenterology and Hepatology · 2016 · 31 citations · Full text

Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents

Marvin J. Meyers, Elizabeth J. Anderson, Sarah A. McNitt et al. · Bioorganic & Medicinal Chemistry · 2015 · 29 citations · Full text

, , +8

Rows per page

1–5 of 5